摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (4S)-4-(t-butyldimethylsilyloxy)-5-oxopentanoate | 82065-62-1

中文名称
——
中文别名
——
英文名称
methyl (4S)-4-(t-butyldimethylsilyloxy)-5-oxopentanoate
英文别名
methyl (4S)-4-[tert-butyl(dimethyl)silyl]oxy-5-oxopentanoate
methyl (4S)-4-(t-butyldimethylsilyloxy)-5-oxopentanoate化学式
CAS
82065-62-1
化学式
C12H24O4Si
mdl
——
分子量
260.406
InChiKey
QWVXHZMJGPQQBC-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.53
  • 重原子数:
    17
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:58b441a674f4a5e8457a1667091c7d01
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES<br/>[FR] COMPOSITIONS POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES
    申请人:UNIV SOUTHERN CALIFORNIA
    公开号:WO2014130894A1
    公开(公告)日:2014-08-28
    This invention provides compounds, methods and compositions for the treatment of inflammatory diseases, comprising the timely administration of a provided compound, which has a structure related to an endogenously formed lipid mediator. One embodiment of the present invention is directed to a compound selected from a group having the general formula A.
    这项发明提供了用于治疗炎症性疾病的化合物、方法和组合物,包括及时给予一种提供的化合物,其结构与内源形成的脂质介质相关。本发明的一个实施例涉及选自具有一般式A的化合物组的化合物。
  • A chiral total synthesis of compactin
    作者:Masahiro Hirama、Mitsuko Uei
    DOI:10.1021/ja00379a037
    日期:1982.7
  • Diastereoconvergent Synthesis of <i>trans</i>-5-Hydroxy-6-Substituted-2-Piperidinones by Addition–Cyclization–Deprotection Process
    作者:Chang-Mei Si、Wei Huang、Zhen-Ting Du、Bang-Guo Wei、Guo-Qiang Lin
    DOI:10.1021/ol5020812
    日期:2014.8.15
    A diastereoselective one-pot approach to access trans-5-hydroxy-6-substituted-2-piperidinones by an addition-cyclization-deprotection process has been developed, in which the stereogenic center at the C-6 position was solely controlled by alpha-OTBS group. The utility of this transformation is demonstrated by the asymmetric synthesis of the enantiomer of (-)-CP-99,994.
  • Stereocontrolled Total Synthesis of the Potent Anti-inflammatory and Pro-resolving Lipid Mediator Resolvin D3 and Its Aspirin-Triggered 17<i>R</i>-Epimer
    作者:Jeremy W. Winkler、Jasim Uddin、Charles N. Serhan、Nicos A. Petasis
    DOI:10.1021/ol400484u
    日期:2013.4.5
    The first total synthesis of stereochemically pure resolvin D3 and aspirin-triggered resolvin D3 is reported. These enzymatic metabolites of docosahexaenoic acid (DHA) have potent anti-inflammatory and pro-resolving actions. The convergent synthetic strategy is based on enantiomerically pure starting materials, and it is highly stereocontrolled.
    报道了立体化学纯的resolvin D3和阿司匹林触发的resolvin D3的首次全合成。这些二十二碳六烯酸 (DHA) 的酶代谢物具有有效的抗炎和促消退作用。收敛合成策略基于对映异构纯的起始材料,并且是高度立体控制的。
查看更多